U.S. Retail REITs Stock News

The RMR Group Inc. has reported past second-quarter 2026 results, with sales rising to US$5.1 million while revenue fell to US$145.63 million, and quarterly net income declining to US$1.01 million, or US$0.05 per diluted share, compared with the prior year period. Over the first six months of fiscal 2026, higher sales but lower revenue coincided with net income improving to US$13.2 million, highlighting a contrast between weaker quarterly profitability and stronger year‑to‑date earnings. We...

Crown Holdings’ recent first-quarter 2026 results showed sales rising to US$3,259 million while net income and earnings per share eased, and the company affirmed a quarterly dividend of US$0.35 per share payable on May 28, 2026. At the same time, Crown announced plans for a new beverage can plant in Northern India capable of producing about 2.20 billion cans annually, supported by long-term customer commitments that underline demand for aluminum packaging. With higher volumes but pressured...

United Airlines Holdings (UAL) stock is back in focus after Q1 2026 results came in ahead of expectations, with management leaning on tighter capacity and pricing to help offset fuel volatility and support margins. See our latest analysis for United Airlines Holdings. The recent 6.8% 1 day and 12.0% 30 day share price returns suggest momentum is rebuilding after a weaker period. The 1 year total shareholder return of 26.0% and 3 year total shareholder return of about 12x indicate longer term...

Moderna published Phase 3 results for its mRNA-1010 flu vaccine in the New England Journal of Medicine. The mRNA flu vaccine showed higher efficacy compared with standard seasonal flu shots. Regulatory filings are in progress in the US, EU, and other regions to seek approval for mRNA-1010. For investors watching NasdaqGS:MRNA, this flu update comes with the stock at $48.79 and a mixed return profile. The share price is up 6.7% over the past week, flat over 30 days, and higher by 58.1% year...

Stock performance and recent context W. R. Berkley (WRB) has seen mixed share performance recently, with the stock near US$66 and returns showing modest movement over the past week and month, but a more pronounced decline over the past 3 months and year. See our latest analysis for W. R. Berkley. Recent trading has been soft, with a 90 day share price return of about a 7% decline and a 1 year total shareholder return of about a 7% decline, even though the 3 and 5 year total shareholder...

Wondering if Robinhood Markets at around US$79 per share is still compelling value or if the easy gains are behind it? This article breaks down what the current price really reflects. The stock has been volatile recently, with an 11% return over the last 7 days, 13.3% over the last 30 days, a 31.4% decline year to date, and a 58.1% return over the last year, which can shift how the market is thinking about both opportunity and risk. Recent coverage has focused on Robinhood's evolving role in...

What recent moves in Veradermics (MANE) might be telling you Veradermics (MANE) has drawn attention after a sharp month return of about 72% and a very large past 3 months move, putting its clinical stage dermatology pipeline and valuation in sharper focus for investors. See our latest analysis for Veradermics. The recent 72% 30 day share price return and very large 90 day move sit alongside a 190.78% year to date share price return, which points to strong upward momentum despite a 4.38% one...

Investors may be wondering whether United Therapeutics at around US$596.76 is still offering value after a strong run, or if the easy gains are already behind it. The stock has recent returns of 4.5% over 7 days, 6.6% over 30 days, 20.1% year to date, 94.4% over 1 year and 181.2% over 3 years. This puts valuation questions front and center for anyone considering it today. Recent coverage has focused on United Therapeutics as a high growth biotech with a strong pipeline and regulatory...

In the past week, Piper Sandler Companies reported first-quarter 2026 revenue of US$475.15 million and net income of US$65.24 million, raised its quarterly dividend to US$0.20 per share, completed a US$61.55 million buyback program, and added healthcare investment banker Patrick McCormack, M.D., as a managing director. Together, the stronger-than-expected revenue, 14% dividend increase, continued share repurchases, and senior healthcare hire highlight management’s focus on shareholder...

Pool Corporation (NasdaqGS:POOL) has announced the immediate departure of CEO Peter D. Arvan. John B. Watwood has been appointed as the new President and CEO, with John E. Stokely becoming Executive Chair. The company has postponed its upcoming Investor Day following the leadership change. Pool enters this leadership transition after a period of weak share price performance, with NasdaqGS:POOL at $188.09 and showing a 10.3% decline over the past week and 35.2% decline over the past year...

Gold Royalty Corp. has reported its first-quarter 2026 results, with sales rising to US$7.18 million and net income reaching US$1.77 million. The shift from a net loss a year earlier to positive earnings per share, alongside ample cash and no debt, highlights a marked improvement in financial flexibility. We'll examine how Gold Royalty's return to profitability and reaffirmed 2026 production outlook may influence its longer-term investment narrative. The future of work is here. Discover the...

DICK'S Sporting Goods (DKS) is in focus after recent share price moves, with the stock last closing at $226.50. Investors are weighing this performance against the company’s broader returns and current business profile. See our latest analysis for DICK'S Sporting Goods. The latest 5.11% 1 day share price return adds to a 13.44% 30 day share price return and a 23.16% 1 year total shareholder return. This suggests momentum has been building rather than fading recently. If DICK'S Sporting Goods...

Centrus Energy (LEU) opened Q1 2026 with revenue of US$76.7 million and basic EPS of US$0.51, against a backdrop of forecast earnings growth of about 7.0% a year and revenue growth around 5.1%. Over recent quarters the company has seen revenue range between US$73.1 million and US$154.5 million with basic EPS between US$0.21 and US$3.21. Trailing 12 month EPS sits at US$3.25 on revenue of US$452.3 million and net income of US$60.6 million, framing a set of results where profit growth and...

In late April 2026, Glaukos Corporation reported first‑quarter 2026 sales of US$150.57 million, a rise from US$106.66 million a year earlier, alongside a net loss of US$19.78 million, and raised its 2026 net sales guidance to a range of US$620 million to US$635 million. At the same time, Glaukos highlighted a broadened ophthalmic portfolio and long-term growth plan, even as insider share sales and continued losses underline ongoing execution and commercialization risks. We’ll now explore how...

Insmed (NasdaqGS:INSM) has launched a national "Suspect Bronchiectasis" awareness initiative with TV personality and patient advocate Ty Pennington. The company is partnering with the American Thoracic Society on a quality improvement effort aimed at reducing underdiagnosis of bronchiectasis among clinicians. The campaign targets both physicians and undiagnosed patients, with potential implications for uptake of Insmed therapies such as Brinsupri and ARIKAYCE. For investors tracking Insmed,...

Wondering if MKS at around US$293.77 is still offering value after a strong run, or if you might be turning up late to the story. The stock has posted returns of 10.7% over 7 days, 24.0% over 30 days, 74.5% year to date, 298.2% over 1 year and 255.7% over 3 years, with a 5 year return of 83.9%. These moves have kept MKS firmly on investors' radars, as sustained share price strength often raises questions about how the current price lines up with underlying fundamentals. With this context in...

Amcor (NYSE:AMCR) has posted Q3 2026 revenue of about US$5.9 billion, with basic EPS of US$0.60 on net income of US$278 million, while the trailing twelve months show revenue of roughly US$22.2 billion and basic EPS of US$1.51 on net income of US$677 million. Over recent quarters, the company has seen revenue move from US$5.1 billion in Q4 2025 to US$5.7 billion in Q1 2026 and US$5.4 billion in Q2 2026. Basic EPS shifted from a loss of US$0.10 in Q4 2025 to US$0.57 in Q1 2026 and US$0.38 in...

In early May 2026, Autodesk launched “Autodesk for Small Business,” introducing a dedicated Small Business Hub, more flexible Autodesk Flex token purchasing, and May-only promotions including a free AutoCAD Professional Certification exam voucher for buyers. The initiative highlights Autodesk’s push to better serve small teams in Design and Make industries by simplifying product discovery, lowering upfront commitments, and incorporating small-business feedback directly into product...

What recent performance signals for Omeros (OMER) Without a single defining headline driving trading, Omeros (OMER) has still drawn attention after a strong month and past 3 months, alongside sizeable 1 year and 3 year total returns. At a recent price of $14.83 and a market cap of about $1.06b, the stock reflects a clinical stage pipeline built around immunologic and rare disease programs rather than current product revenue. See our latest analysis for Omeros. For context, Omeros has paired a...

To figure out whether MP Materials stock still offers value after its strong run, you need to separate a compelling story about rare earths from what the current share price already reflects. The stock last closed at US$72.65, with returns of 18.5% over 7 days, 42.0% over 30 days, 32.2% year to date, 207.6% over 1 year, 221.7% over 3 years and 192.9% over 5 years, so recent performance is front of mind for many investors. Recent news around rare earth supply chains and US focused production...

Wondering if Nextpower at US$126.08 is still offering value after its strong run, or if you might be late to the story. The stock shows returns of 10.3% over 7 days, 16.7% over 30 days, 35.9% year to date and 188.1% over 1 year, with a 3 year return of 279.4%. This naturally raises questions about what is already priced in. Recent coverage has focused on how quickly Nextpower's share price has moved relative to its sector peers and on the growing investor interest in companies linked to...

Brookdale Senior Living reported past first-quarter 2026 results with revenue of US$764.86 million and a net loss of US$6.89 million, a sharp improvement from the prior year. The company also boosted occupancy and revenue per available unit while refinancing 2027 debt and generating over US$100 million from community sales. Next, we’ll examine how stronger occupancy and a reduced net loss reshape Brookdale’s existing investment narrative and risk-reward balance. Outshine the giants: these 18...

Wondering whether Academy Sports and Outdoors at around US$54.46 is still priced attractively, or if most of the easy upside is gone? This article focuses squarely on what the numbers say about value. The stock has returned 4.4% year to date and 36.7% over the past year, while the past 30 days and 7 days show declines of 4.8% and 0.7%. This can change how the market is thinking about risk and opportunity. Recent coverage around Academy Sports and Outdoors has centered on how the business is...

Carvana (CVNA) is back in focus after reporting first quarter 2026 results, with revenue of US$6.43b, net income of US$250 million, and diluted EPS from continuing operations of US$1.69. See our latest analysis for Carvana. Carvana's share price has been volatile, with a 22.89% 1 month share price return and a 2.72% year to date decline, alongside a very large 3 year total shareholder return that signals strong long term momentum. If Carvana’s moves have you thinking about what else is out...